Abstract: The present invention relates to a medical herb composition for reducing shedding of mammal hair and a method for preparing the same. The medical herb composition comprises: a first herb material selected from the group consisting of Ginseng Radix, Astragali Radix, Batatatis Rhizoma, Zizyphi Fructus, Tremella, Codonopsis Pilosula, or the combination thereof; a second herb material selected from the group consisting of Angelicae Radix, Rehmanniae Preparata Radix, Longanae Arillus, Lycii Fructus, Paeonia lactiflora, or the combination thereof; and a third herb material selected from the group consisting of Rehmanniae Radix, Ligustrum Lucidum, Eclipta prostrata, Dendrobium hancockii, Polygonum multiflorun (i.e. Dioscorea bulbifera or Cynanchum wilfordi), or the combination thereof. The medical herb composition of the present invention can reduce shedding of mammal hair, promote the growth of hair, and also can efficiently improve vitality, skin condition, and complexion.
Abstract: The invention provides a Pyracantha koidzumii extract and new compounds isolated from the extract and their derivatives. This extract and these compounds have activity in inhibiting tyrosinase.
Type:
Grant
Filed:
January 23, 2009
Date of Patent:
November 23, 2010
Assignee:
Taipei Medical University
Inventors:
Mei-Hsien Lee, Feng-Lin Hsu, Yan-Ling Liu
Abstract: The present invention provides herbal formulas, and compositions thereof, that can treat or reduce the severity, intensity, or duration of food allergy and food allergy related symptoms. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutically acceptable carriers or excipients, and may be administered prior to, during, or after the development of food allergy-related symptoms in a patient in need thereof.
Abstract: The present invention provides a cell activation agent, a collagen production accelerator, a whitening agent, an antioxidant, an anti-inflammatory agent, an aromatase activity accelerator, a protease activity accelerator, a skin external preparation, and food, which all contain an extract of Hibiscus makinoi.
Type:
Grant
Filed:
September 4, 2007
Date of Patent:
September 14, 2010
Assignee:
Noevir Co., Ltd.
Inventors:
Hiroko Kikuchi, Masaki Arashima, Sayaka Aramaki, Hiroko Yoshida
Abstract: Disclosed is an effervescent composition that includes an effervescent agent and cranberry extract, preferably in an amount sufficient to decrease the measurable amount of bacteria present in the urine of an individual having a urinary tract infection.
Type:
Grant
Filed:
January 16, 2004
Date of Patent:
August 31, 2010
Assignee:
Amerilab Technologies, Inc.
Inventors:
Mary Aldritt, Robert E. Lee, Fred Wehling
Abstract: An animal feed supplement includes fish meal as a source of omega 3 long chain fatty acids for inclusion in the diet of an animal. The animal feed supplement also includes at least one naturally-occurring antioxidant; at least one synthetic antioxidant; an antibacterial agent; an anti-mold/anti-fungal agent; and an anti-chemical activity agent. The omega 3 long chain fatty acids are provided at a level which maximizes the nutritional value of food produce from the animal, but without taint of the food produce. The feed supplement is greater than 5% of the total dietary intake of the animal.
Abstract: Plant seed extract compositions obtained by washing a defatted plant seed with water, and extracting the resulting washed seed product with an organic solvent and safflower seed extract compositions wherein the weight ratio of the total content of (a) p-coumaroylserotonin, feruloylserotonin, p-coumaroylserotonin glycoside, and feruloylserotonin glycoside to (b) 2-hydroxyarctiin is 1:0.01 to 0.2, are effective for reducing the risk of developing atherosclerosis and diseases caused by atherosclerosis and also exhibit a reduced tendency to cause diarrhea.
Abstract: A method of treating an amyloid disease in a patient or inhibiting the formation, deposition, accumulation, or persistence, of amyloid fibrils, amylin fibrils, or islet amyloid fibrils, and/or dissolving or disrupting pre-formed or pre-deposited amyloid fibrils in type II diabetes in a mammalian subject. In the method a therapeutically effective amount of plant matter form the genus Uncaria, species Tomentosa is administered, preferably from the inner bark or root tissue of Uncaria Tomentosa.
Abstract: The present invention relates to a method for preparing purified extract from wild ginseng showing anticancer activity such as inhibitory of cancer cell adherence, inhibitory of cancer cell metastasis and immunostimulating effect and a composition comprising the same prepared by inventive method. The composition have potent anticancer activity, therefore, it can be used as the therapeutics for treating and preventing various cancer diseases.
Type:
Grant
Filed:
August 2, 2004
Date of Patent:
June 29, 2010
Assignee:
Seocksanteo Medical Co., Ltd.
Inventors:
Yong Jin Park, In Sop Shim, Gyu Yong Song
Abstract: The present invention is directed to chemoprotectant precursor compositions provided from crucifer seeds and sprouts and methods for their preparation. Treatment of aqueous extracts from crucifer seeds or sprouts with adsorbents substantially increases the ratio of certain highly chemoprotectant precursor compounds (alkyl glucosinolates such as glucoraphanin, a.k.a. sulforaphane glucosinolate) to undesirable compounds such as indole glucosinolates (for example 4-hydroxyglucobrassicin). The method provides an extract which has a ratio of glucoraphanin to 4-hydroxyglucobrassicin of about 70 or greater. The resulting extract has improved color and odor and may be dried or used directly as an additive in a variety of foodstuffs.
Type:
Grant
Filed:
August 9, 2005
Date of Patent:
June 29, 2010
Assignee:
Kraft Foods Global Brands LLC
Inventors:
Leslie G. West, George W. Haas, Nathan Matusheski
Abstract: Disclosed herein are compositions for controlling androgen activity in target organs and cells through the modulation of a 5-?-reductase activity. In certain aspects, these compositions are employed to modulate androgenic activity by inhibiting the formation and availability of active androgen in target cells. As a result, the present invention is directed toward the treatment of a wide variety of conditions including, but not limited to, the treatment of prostatic hyperplasia, prostatic cancer, hirsutism, acne, male pattern baldness, seborrhea, and other diseases related to androgen hyperactivity. Several of these compositions have been shown to effectively decrease body weight, and in some cases, to decrease the weight of an androgen-dependent body organ, such as the prostate and other organs.
Abstract: The present invention provides a composition comprising a green-yellow vegetable (e.g., broccoli, spinach, parsley, komatsuna (Brassica rapa L.), Japanese radish leaves) and a light-colored vegetable (e.g., lettuce, cabbage, celery), the composition having the following effects: (1) inhibiting the generation of blood lipid peroxide; (2) lowering blood TBARS levels or suppressing the elevation of blood TBARS levels; (3) increasing blood vitamin E levels; (4) enhancing blood antioxidant activity; (5) enhancing blood TRAP levels; (6) lowering blood active oxygen levels or suppressing the elevation of blood active oxygen levels; and (7) preventing or treating diabetic complications.
Abstract: Disclosed herein are extracts of blue green algae, such as Aphanizomenon flos aquae, that are enriched for a selectin ligand, such as an L-selectin ligand. Selectin ligands isolated from blue-green algae cells are disclosed herein. Methods are described for isolating these selectin ligands. The purified selectin ligands are of use in inducing stem cell mobilization in a subject. Thus, methods for inducing stem cell isolation that include administering a therapeutically effective amount of the extract enriched form the selectin ligand, or an isolated selectin ligand, are disclosed herein.
Abstract: The present invention relates to methods and compositions for maintaining or enhancing feeding characteristics of post-receiving stressed animals using a saponin composition. In an embodiment, the invention includes a method for increasing feed intake of an animal after a post-receiving stressful event comprising administering an effective amount of a composition comprising saponins to the animal. In an embodiment, the invention includes a method for increasing weight gain of an animal after a post-receiving stressful event comprising administering an effective amount of a composition comprising saponins to the animal.
Abstract: The present invention relates to a drink composition comprising active agents, and to a method for composing a drink. Specifically, the invention is directed to a drink composition to be used during long-lasting sports activities demanding constant energy supply and intensive concentration. The drink composition of the invention in characterized in that it contains glucose, fructose, guarana, and a physiologically active amount of a pycnogenol extract. The method of the invention in characterized in that the active agents are individually selected on the basis of the characteristics of the target group, single user and/or conditions of use, said active agents having at least partly complementing actions.
Abstract: The present invention provides a process for preparing an extract of Rhus verniciflua by using water and organic solvents to extract active ingredients, which comprises (a) adding water or a mixture of water and alcohol as the solvent to Rhus verniciflua to extract the soluble components, then filtering the resultant product to obtain a filtrate, and concentrating and drying the filtrate to obtain a solid fraction; (b) re-extracting the solid fraction obtained in the previous step with highly purified ethanol, then filtering the resultant product to obtain a filtrate, and concentrating and drying the filtrate to obtain a solid fraction; (c) adding a saturated hydrocarbon having 5 to 7 carbon atoms to the solid fraction obtained in the previous step to dissolve allergy-inducing components, and then removing the hydrocarbon to obtain a solid fraction; and (d) adding water to the solid fraction obtained in the previous step to extract water-soluble components.
Type:
Grant
Filed:
September 8, 2005
Date of Patent:
December 8, 2009
Assignee:
AZI Company, Ltd
Inventors:
Won-Cheol Chol, Sang-Jae Park, Sung-Pil Kwon
Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a neurogenic bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
Abstract: Processes for preparing extracts of natural products such as plant material, and for preparing purified extracts from crude extracts of natural products, by extraction with hot gas. Apparatus suitable for use in preparing extracts of natural products are also described.
Type:
Grant
Filed:
May 7, 2002
Date of Patent:
November 24, 2009
Assignee:
GW Pharma Limited
Inventors:
Brian Whittle, Geoffrey Guy, David Downs, David Pate
Abstract: A method of processing seaweed, preferably a brown seaweed, comprises the following steps: (I) treating seaweed with an alcohol having one to six carbon atoms, preferably ethanol, to form an alcoholic fraction and an insoluble first seaweed residue; (II) separating the alcoholic fraction; (III) removing the alcohol from the alcoholic fraction to form a concentrate comprising biologically active low molecular weight compounds; (iv) extracting the first seaweed residue with an aqueous solution at a pH of less than 6 to form an aqueous first extract and an insoluble second seaweed residue; (v) optionally concentrating the first extract; and (vi) adjusting the pH of the resulting concentrated extract to a value in the range of 5 to 8 to obtain a first polysaccharide, fraction comprising a mixture of laminaran and fucoidan.
Type:
Grant
Filed:
July 23, 2004
Date of Patent:
November 3, 2009
Assignee:
Pacific Institute of Bioorganic Chemistry, Far East Branch of the Russian Academy of Sciences